To determine if you are eligible for one or more of our studies, please contact the ACRU team at 314-747-3495 or asthma-research@wustl.edu.
Purpose
The purpose of this study is to find out if people should take an asthma controller medication based on the type of cells present in their airway.
What does the study entail?
If you are eligible for this study you will complete 9 study visits and 8 scheduled telephone calls across 1 year. Study visits are about 1-4 hours long and each phone call is about 10 minutes long. During these visits there will be certain tests involved, you will fill out questionnaires, provide a medical history and be given a study medication.
Compensation for participation
The total compensation for the entire study is up to $1135.
Contact
To find out if you are eligible for this study please contact the ACRU team at 314-747-3495 or asthma-research@wustl.edu.
Purpose
The purpose of this study is to evaluate the effects of dupilumab, compared with placebo on airway inflammation in patients with persistent asthma
What does the study entail?
The main study is approximately 29 weeks and has 3 parts. A screening period, a treatment period and a follow-up period. You will continue to take the asthma medication you are currently on in addition to the study medication. There are a total of 12 study visits all done at the Washington University Medical Campus.
Compensation for participation
The total compensation for the entire study is up to $2,100. Asthma medication is also provided if you are enrolled in the study.
Contact
To find out if you are eligible for this study please contact the ACRU team at 314-747-3495 or asthma-research@wustl.edu. If you have any additional questions about this study please contact the ACRU team at 314-747-3495 or asthma-research@wustl.edu.